Welcome
Support Centre
10 January 2009 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Randomised controlled trial of the use of an arthritis self-management programme in primary care
ISRCTN ISRCTN74878628
ClinicalTrials.gov identifier
Public title Randomised controlled trial of the use of an arthritis self-management programme in primary care
Scientific title
Acronym DASH
Serial number at source G9900306
Study hypothesis 1. Whether participation in an arthritis self-management programme plus provision of a specially designed education booklet improves the quality of life and other psycho-social outcomes of general practice patients with osteo-arthritis of the knees and/or hips when compared with provision of an education booklet alone.
2. In addition, whether the arthritis self-management programme is a cost-effective intervention for the target population.
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Arthritis
Participants - inclusion criteria 1. Age 45 years or above
2. Diagnosis of osteoarthritis from General Practitioner (GP) affecting 'central' joints, i.e. neck, shoulders, hips and knees but not lumbar spine alone
3. Duration of problem of at least three months and at least two visits to the GP within the past year because of related problems (eg pain, functional disability)
4. Screening question to patient to establish whether significant pain and/or functional disability associated with the condition during the past month
Participants - exclusion criteria 1. Too immobile to be able to get to the surgery for the group.
2. Understanding of English insufficient to be able to participate in the group.
3. Referred for consideration of surgery for arthritis.
4. Patients with lumbar back pain alone (this group may form the basis of subsequent trial)
5. Patients with neurological signs e.g. related to cervical disorders
6. Known cognitive impairment or inability to complete questionnaires
Anticipated start date 01/06/2000
Anticipated end date 30/06/2004
Status of trial Completed
Patient information material
Target number of participants 1000
Interventions Participants who satisfy the inclusion criteria and consent to the trial will be randomised to one of two groups.

1. Group A will receive a leaflet especially designed for the study incorporating information about arthritis and its management.

2. Group B will receive the same leaflet, but also be invited to participate in the intervention involving the Arthritis Self-Management Plan. This group intervention consists of six weekly sessions of 2.5 h each in groups of 12-15 members. The intervention is delivered by a lay member of Arthritis Care, who themselves will have arthritis, at a 'neutral' venue close to the surgery premises. Areas covered within the six sessions include: basic information about arthritis and its treatment, principles of pain management, the benefits of exercise, principles and practice of problem solving and goal setting, strategies for dealing with depression and anger and communication skills to be used with family and health professionals.
Primary outcome measure(s) The primary outcome is Quality of Life, as measured by the SF 36
Secondary outcome measure(s) 1. Functional Disability, measured using the WOMAC
2. Control over symptoms measured using the Arthritis Self-Efficacy Scale
3. Anxiety and Depression measured using the HADS and Cost-effectiveness measured using the CSRI
Sources of funding Medical Research Council (UK)
Trial website
Publications
Contact name Dr  Marta  Buszewicz
  Address Department of Primary Care and Population Sciences
Archway Resource Centre
2nd Floor Holborn Union Building
Highgate Hill
  City/town London
  Zip/Postcode N19 3UA
  Country United Kingdom
  Email
Sponsor Medical Research Council (MRC) (UK)
  Address 20 Park Crescent
  City/town London
  Zip/Postcode W1B 1AL
  Country United Kingdom
  Tel +44 (0)20 7636 5422
  Fax +44 (0)20 7436 6179
  Email clinical.trial@headoffice.mrc.ac.uk
  Sponsor website: http://www.mrc.ac.uk
Date applied 23/10/2000
Last edited 24/04/2007
Date ISRCTN assigned 23/10/2000
Submit your trial protocol Top studies in medical research Submit to Trials journal
© ISRCTN


BioMed Central